Crimean-Congo Hemorrhagic Fever Virus Entry into Host Cells Occurs through the Multivesicular Body and Requires ESCRT Regulators

1. Estrada-PenaA, Ruiz-FonsF, AcevedoP, GortazarC, de la FuenteJ (2013) Factors driving the circulation and possible expansion of Crimean-Congo haemorrhagic fever virus in the western Palearctic. J Appl Microbiol 114: 278–286.

2. WhitehouseCA (2004) Crimean-Congo hemorrhagic fever. Antiviral Res 64: 145–160.

3. ErgonulO (2006) Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6: 203–214.

4. VorouR, PierroutsakosIN, MaltezouHC (2007) Crimean-Congo hemorrhagic fever. Curr Opin Infect Dis 20: 495–500.

5. Schmaljohn CS, Nichol S T. (2007) Bunyaviridae. In: Knipe DM, Howley P M., editor. Fields Virology. Philadelphia: Lippincott Williams & Wilkins. pp. 1741–1789.

6. SanchezAJ, VincentMJ, NicholST (2002) Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J Virol 76: 7263–7275.

7. SanchezAJ, VincentMJ, EricksonBR, NicholST (2006) Crimean-congo hemorrhagic fever virus glycoprotein precursor is cleaved by Furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein. J Virol 80: 514–525.

8. BergeronE, VincentMJ, NicholST (2007) Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity. J Virol 81: 13271–13276.

9. EricksonBR, DeydeV, SanchezAJ, VincentMJ, NicholST (2007) N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport. Virology 361: 348–355.

10. BenteDA, ForresterNL, WattsDM, McAuleyAJ, WhitehouseCA, et al. (2013) Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res 100: 159–189.

11. Bertolotti-CiarletA, SmithJ, StreckerK, ParagasJ, AltamuraLA, et al. (2005) Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins. J Virol 79: 6152–6161.

12. XiaoX, FengY, ZhuZ, DimitrovDS (2011) Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor. Biochem Biophys Res Commun 411: 253–258.

13. GarrisonAR, RadoshitzkySR, KotaKP, PegoraroG, RuthelG, et al. (2013) Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway. Virology 444: 45–54.

14. SimonM, JohanssonC, MirazimiA (2009) Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent. J Gen Virol 90: 210–215.

15. FlickR, FlickK, FeldmannH, ElghF (2003) Reverse genetics for crimean-congo hemorrhagic fever virus. J Virol 77: 5997–6006.

16. DumasJJ, MerithewE, SudharshanE, RajamaniD, HayesS, et al. (2001) Multivalent endosome targeting by homodimeric EEA1. Mol Cell 8: 947–958.

17. BucciC, PartonRG, MatherIH, StunnenbergH, SimonsK, et al. (1992) The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell 70: 715–728.

18. LiG, StahlPD (1993) Structure-function relationship of the small GTPase rab5. J Biol Chem 268: 24475–24480.

19. StenmarkH, PartonRG, Steele-MortimerO, LutckeA, GruenbergJ, et al. (1994) Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J 13: 1287–1296.

20. HirotaY, KuronitaT, FujitaH, TanakaY (2007) A role for Rab5 activity in the biogenesis of endosomal and lysosomal compartments. Biochem Biophys Res Commun 364: 40–47.

21. RosenfeldJL, MooreRH, ZimmerKP, Alpizar-FosterE, DaiW, et al. (2001) Lysosome proteins are redistributed during expression of a GTP-hydrolysis-defective rab5a. J Cell Sci 114: 4499–4508.

22. LozachPY, ManciniR, BittoD, MeierR, OestereichL, et al. (2010) Entry of bunyaviruses into mammalian cells. Cell Host Microbe 7: 488–499.

23. WoodmanPG, FutterCE (2008) Multivesicular bodies: co-ordinated progression to maturity. Curr Opin Cell Biol 20: 408–414.

24. GruenbergJ, StenmarkH (2004) The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol 5: 317–323.

25. PasqualG, RojekJM, MasinM, ChattonJY, KunzS (2011) Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog 7: e1002232.

26. KhorR, McElroyLJ, WhittakerGR (2003) The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic 4: 857–868.

27. Le BlancI, LuyetPP, PonsV, FergusonC, EmansN, et al. (2005) Endosome-to-cytosol transport of viral nucleocapsids. Nat Cell Biol 7: 653–664.

28. LuyetPP, FalguieresT, PonsV, PattnaikAK, GruenbergJ (2008) The ESCRT-I subunit TSG101 controls endosome-to-cytosol release of viral RNA. Traffic 9: 2279–2290.

29. KobayashiT, VischerUM, RosnobletC, LebrandC, LindsayM, et al. (2000) The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol Biol Cell 11: 1829–1843.

30. MetzelaarMJ, WijngaardPL, PetersPJ, SixmaJJ, NieuwenhuisHK, et al. (1991) CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 266: 3239–3245.

31. SadoulR (2006) Do Alix and ALG-2 really control endosomes for better or for worse? Biol Cell 98: 69–77.

32. VanlandinghamPA, CeresaBP (2009) Rab7 regulates late endocytic trafficking downstream of multivesicular body biogenesis and cargo sequestration. J Biol Chem 284: 12110–12124.

33. VonderheitA, HeleniusA (2005) Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes. PLoS Biol 3: e233.

34. ZerialM, McBrideH (2001) Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2: 107–117.

35. FengY, PressB, Wandinger-NessA (1995) Rab 7: an important regulator of late endocytic membrane traffic. J Cell Biol 131: 1435–1452.

36. BuchholzUJ, FinkeS, ConzelmannKK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73: 251–259.

37. BowmanEJ, SiebersA, AltendorfK (1988) Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A 85: 7972–7976.

38. FretzM, JinJ, ConibereR, PenningNA, Al-TaeiS, et al. (2006) Effects of Na+/H+ exchanger inhibitors on subcellular localisation of endocytic organelles and intracellular dynamics of protein transduction domains HIV-TAT peptide and octaarginine. J Control Release 116: 247–254.

39. AkaikeN, HarataN (1994) Nystatin perforated patch recording and its applications to analyses of intracellular mechanisms. Jpn J Physiol 44: 433–473.

40. MaciaE, EhrlichM, MassolR, BoucrotE, BrunnerC, et al. (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10: 839–850.

41. WangLH, RothbergKG, AndersonRG (1993) Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 123: 1107–1117.

42. Fernandez-BorjaM, WubboltsR, CalafatJ, JanssenH, DivechaN, et al. (1999) Multivesicular body morphogenesis requires phosphatidyl-inositol 3-kinase activity. Curr Biol 9: 55–58.

43. FutterCE, CollinsonLM, BackerJM, HopkinsCR (2001) Human VPS34 is required for internal vesicle formation within multivesicular endosomes. J Cell Biol 155: 1251–1264.

44. VlahosCJ, MatterWF, HuiKY, BrownRF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241–5248.

45. FaderCM, ColomboMI (2009) Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ 16: 70–78.

46. BishopN, WoodmanP (2000) ATPase-defective mammalian VPS4 localizes to aberrant endosomes and impairs cholesterol trafficking. Mol Biol Cell 11: 227–239.

47. LiscumL, FaustJR (1989) The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. J Biol Chem 264: 11796–11806.

48. BeattyWL (2008) Late endocytic multivesicular bodies intersect the chlamydial inclusion in the absence of CD63. Infect Immun 76: 2872–2881.

49. HigginsME, DaviesJP, ChenFW, IoannouYA (1999) Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol Genet Metab 68: 1–13.

50. KobayashiT, BeuchatMH, LindsayM, FriasS, PalmiterRD, et al. (1999) Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat Cell Biol 1: 113–118.

51. SimonM, JohanssonC, LundkvistA, MirazimiA (2009) Microtubule-dependent and microtubule-independent steps in Crimean-Congo hemorrhagic fever virus replication cycle. Virology 385: 313–322.

52. SokolJ, Blanchette-MackieJ, KruthHS, DwyerNK, AmendeLM, et al. (1988) Type C Niemann-Pick disease. Lysosomal accumulation and defective intracellular mobilization of low density lipoprotein cholesterol. J Biol Chem 263: 3411–3417.

53. CaretteJE, RaabenM, WongAC, HerbertAS, ObernostererG, et al. (2011) Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477: 340–343.

54. CoteM, MisasiJ, RenT, BruchezA, LeeK, et al. (2011) Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477: 344–348.

55. JaeLT, RaabenM, HerbertAS, KuehneAI, WirchnianskiAS, et al. (2014) Virus entry. Lassa virus entry requires a trigger-induced receptor switch. Science 344: 1506–1510.

56. TrowbridgeIS, CollawnJF, HopkinsCR (1993) Signal-dependent membrane protein trafficking in the endocytic pathway. Annu Rev Cell Biol 9: 129–161.

57. MellmanI (1996) Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 12: 575–625.

58. MellmanI, WarrenG (2000) The road taken: past and future foundations of membrane traffic. Cell 100: 99–112.

59. LakadamyaliM, RustMJ, ZhuangX (2006) Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 124: 997–1009.

60. PearseBM, SmithCJ, OwenDJ (2000) Clathrin coat construction in endocytosis. Curr Opin Struct Biol 10: 220–228.

61. WasanoK, HirakawaY (1994) Lamellar bodies of rat alveolar type 2 cells have late endosomal marker proteins on their limiting membranes. Histochemistry 102: 329–335.

62. CalafatJ, NijenhuisM, JanssenH, TulpA, DusseljeeS, et al. (1994) Major histocompatibility complex class II molecules induce the formation of endocytic MIIC-like structures. J Cell Biol 126: 967–977.

63. FinziA, BrunetA, XiaoY, ThibodeauJ, CohenEA (2006) Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments. J Virol 80: 9789–9797.

64. HutagalungAH, NovickPJ (2011) Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev 91: 119–149.

65. StenmarkH (2009) Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 10: 513–525.

66. GaullierJM, SimonsenA, D'ArrigoA, BremnesB, StenmarkH, et al. (1998) FYVE fingers bind PtdIns(3)P. Nature 394: 432–433.

67. GilloolyDJ, MorrowIC, LindsayM, GouldR, BryantNJ, et al. (2000) Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J 19: 4577–4588.

68. BacheKG, BrechA, MehlumA, StenmarkH (2003) Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J Cell Biol 162: 435–442.

69. CantleyLC (2002) The phosphoinositide 3-kinase pathway. Science 296: 1655–1657.

70. FrumanDA, RommelC (2014) PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov 13: 140–156.

71. XuH, LiX, LiuD, LiJ, ZhangX, et al. (2013) Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature 496: 523–527.

72. National Institutes of Health (NIH). ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT01297491. Accessed February 19, 2014.

73. OginoM, EbiharaH, LeeBH, ArakiK, LundkvistA, et al. (2003) Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test. Clin Diagn Lab Immunol 10: 154–160.

74. HigaMM, PetersenJ, HooperJ, DomsRW (2012) Efficient production of Hantaan and Puumala pseudovirions for viral tropism and neutralization studies. Virology 423: 134–142.

75. BrownKS, SafronetzD, MarziA, EbiharaH, FeldmannH (2011) Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus. J Virol 85: 12781–12791.

76. de BoerSM, KortekaasJ, de HaanCA, RottierPJ, MoormannRJ, et al. (2012) Heparan sulfate facilitates Rift Valley fever virus entry into the cell. J Virol 86: 13767–13771.

77. HollidgeBS, NedelskyNB, SalzanoMV, FraserJW, Gonzalez-ScaranoF, et al. (2012) Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes. J Virol 86: 7988–8001.

78. PobjeckyN, SmithJ, Gonzalez-ScaranoF (1986) Biological studies of the fusion function of California serogroup Bunyaviruses. Microb Pathog 1: 491–501.

79. JinM, ParkJ, LeeS, ParkB, ShinJ, et al. (2002) Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology 294: 60–69.

80. SantosRI, RodriguesAH, SilvaML, MortaraRA, RossiMA, et al. (2008) Oropouche virus entry into HeLa cells involves clathrin and requires endosomal acidification. Virus Res 138: 139–143.

81. HofmannH, LiX, ZhangX, LiuW, KuhlA, et al. (2013) Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines. J Virol 87: 4384–4394.

82. KobasaD, RodgersME, WellsK, KawaokaY (1997) Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J Virol 71: 6706–6713.

83. NiwaH, YamamuraK, MiyazakiJ (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193–199.

84. MuhlbergerE, WeikM, VolchkovVE, KlenkHD, BeckerS (1999) Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol 73: 2333–2342.

85. SaeedMF, KolokoltsovAA, DaveyRA (2006) Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies. J Virol Methods 135: 143–150.

86. DaveyRA, ZuoY, CunninghamJM (1999) Identification of a receptor-binding pocket on the envelope protein of friend murine leukemia virus. J Virol 73: 3758–3763.

87. KolokoltsovAA, DenigerD, FlemingEH, RobertsNJJr, KarpilowJM, et al. (2007) Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J Virol 81: 7786–7800.

88. KolokoltsovAA, FlemingEH, DaveyRA (2006) Venezuelan equine encephalitis virus entry mechanism requires late endosome formation and resists cell membrane cholesterol depletion. Virology 347: 333–342.

89. MillerME, AdhikaryS, KolokoltsovAA, DaveyRA (2012) Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection. J Virol 86: 7473–7483.

90. KolokoltsovAA, AdhikaryS, GarverJ, JohnsonL, DaveyRA, et al. (2012) Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin. Arch Virol 157: 121–127.